Viridian Therapeutics, Inc. (VRDN)
NASDAQ·Healthcare·Biotechnology
$21.44
-3.14%
Mkt Cap $2.47B
Analyst Ratings
Buy
21
Hold
1
Sell
0
Price Target (41 analysts)
$36.88
Range $26.00 – $45.00
Implied Upside
+72.0%
Consensus $36.88 vs current $21.44
NASDAQ·Healthcare·Biotechnology
$21.44
-3.14%
Mkt Cap $2.47B
Buy
21
Hold
1
Sell
0
Price Target (41 analysts)
$36.88
Range $26.00 – $45.00
+72.0%
Consensus $36.88 vs current $21.44